ACCESSION: MSBNK-SMB_Measured-HSA015P0258003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 35
COMMENT: RAW_SPEC {'EL03_pos_9975': {'bp': 1185850.0, 'sum': 2127762.0}, 'EL03_pos_10033': {'bp': 965088.0, 'sum': 1963620.0}, 'Blanc1-pos_10341': {'bp': 424816.0, 'sum': 894450.0}, 'EL24_pos_10065': {'bp': 278805.0, 'sum': 487271.0}, 'EL17_pos_10089': {'bp': 271776.0, 'sum': 476963.0}, 'EL07_pos_10065': {'bp': 267729.0, 'sum': 474544.0}, 'EL13_pos_10078': {'bp': 264444.0, 'sum': 458498.0}, 'EL08_pos_10066': {'bp': 256740.0, 'sum': 464488.0}, 'EL14_pos_10084': {'bp': 245655.0, 'sum': 463349.0}, 'EL18_pos_10059': {'bp': 227446.0, 'sum': 412871.0}, 'EL02_pos_10149': {'bp': 225426.0, 'sum': 434481.0}, 'EL16_pos_10066': {'bp': 224222.0, 'sum': 425329.0}, 'EL15_pos_10100': {'bp': 224070.0, 'sum': 426732.0}, 'EL11_pos_10059': {'bp': 220982.0, 'sum': 409614.0}, 'EL01_pos_10054': {'bp': 220456.0, 'sum': 416371.0}, 'Blanc3-pos_9977': {'bp': 220022.0, 'sum': 383208.0}, 'EL20_pos_10066': {'bp': 215430.0, 'sum': 397543.0}, 'EL06_pos_10097': {'bp': 212948.0, 'sum': 394629.0}, 'EL23_pos_10073': {'bp': 208597.0, 'sum': 405909.0}, 'EL12_pos_10102': {'bp': 206884.0, 'sum': 419378.0}, 'EL05_pos_10126': {'bp': 203402.0, 'sum': 388000.0}, 'EL19_pos_10143': {'bp': 199190.0, 'sum': 422511.0}, 'EL22_pos_10167': {'bp': 193218.0, 'sum': 386498.0}, 'Blanc2-pos_9957': {'bp': 191841.0, 'sum': 351510.0}, 'EL04_pos_10048': {'bp': 191389.0, 'sum': 369557.0}, 'EL10_pos_10053': {'bp': 186064.0, 'sum': 378978.0}, 'EL09_pos_10071': {'bp': 168605.0, 'sum': 347324.0}, 'EL21_pos_10083': {'bp': 166219.0, 'sum': 354332.0}, 'EL18_pos_10112': {'bp': 136151.0, 'sum': 277795.0}, 'EL11_pos_10112': {'bp': 133344.0, 'sum': 265747.0}, 'EL01_pos_10112': {'bp': 128474.0, 'sum': 249963.0}, 'EL08_pos_10118': {'bp': 118065.0, 'sum': 245545.0}, 'EL09_pos_10123': {'bp': 116605.0, 'sum': 268792.0}, 'EL21_pos_10136': {'bp': 112355.0, 'sum': 263110.0}, 'EL04_pos_10108': {'bp': 107842.0, 'sum': 248919.0}}
COMMENT: RETENTION_TIME_STDEV 0.041
COMMENT: PRECURSOR_M/Z_RAW 258.279266
COMMENT: PRECURSOR_M/Z_STDEV 0.000086
COMMENT: PRECURSOR_IN_MS1 mz 258.279231; int 59.452; delta(ppm) 1.320894
COMMENT: PROPOSED_CHARGE_STATE +1; mz 259.282616; int 9.991; cor 0.887
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.334; C16H35NO; [M+H]+; delta(ppm) 0.334277
COMMENT: PROPOSED_MF MS-FINDER 3.048; C16H35NO; [M+H]+; delta(ppm) 0.332285
COMMENT: PROPOSED_MF SIRIUS5_Sirius 10.198; C16H35NO; [M+H]+; delta(ppm) 0.332285
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C16H35NO; [M+H]+; delta(ppm) 0.332285
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.731; C16H35NO; [M+H]+; delta(ppm) 0.332285
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.800; C14H33N4; [M+H]+; delta(ppm) 5.530811
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C16H35NO; [M+H]+; delta(ppm) 0.332285
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; ONHFWHCMZAJCFB-UHFFFAOYSA-N; C16H35NO; Massbank:AU285202 N,N-Dimethyltetradecylamine-N-oxideMyristamine oxideN,N-dimethyltetradecan-1-amine oxide
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.317; CUFBDUDYFHCIOH-UHFFFAOYSA-N; [M+H]+; CC(C)CCCCCCCCCCOCCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.178; XXELRZPDKMOXBT-UHFFFAOYNA-N; [M+H]+; CCCCC(CCC)CCCCCOCCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.154; ONHFWHCMZAJCFB-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCCCCN(C)(C)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.139; DSNJGFLHEVDMHH-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCCOCCN(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.640; ONHFWHCMZAJCFB-UHFFFAOYSA-N; [M+H]+; N,N-dimethyltetradecylamine N-oxide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.588; CUFBDUDYFHCIOH-UHFFFAOYSA-N; [M+H]+; 3-(isotridecyloxy)propylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.588; XXELRZPDKMOXBT-UHFFFAOYNA-N; [M+H]+; 3-(tridecyloxy)propylamine, branched and linear
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.588; DSNJGFLHEVDMHH-UHFFFAOYSA-N; [M+H]+; 2-dodecoxy-N,N-dimethylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ONHFWHCMZAJCFB-UHFFFAOYSA-N; [M+H]+; N,N-dimethyltetradecylamine N-oxide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.349; DSNJGFLHEVDMHH-UHFFFAOYSA-N; [M+H]+; 2-dodecoxy-N,N-dimethylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.348; CUFBDUDYFHCIOH-UHFFFAOYSA-N; [M+H]+; 3-(isotridecyloxy)propylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.297; XXELRZPDKMOXBT-UHFFFAOYNA-N; [M+H]+; 3-(tridecyloxy)propylamine, branched and linear
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.650; ONHFWHCMZAJCFB-UHFFFAOYSA-N; [M+H]+; N,N-dimethyltetradecan-1-amine oxide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.351; ZUEIVCHBEQAIAL-UHFFFAOYSA-N; [M+H]+; 2-(tetradecylamino)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.334; YLSHPGPYXAQLSR-UHFFFAOYSA-N; [M+H]+; 2-(tetradecan-2-ylamino)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.134; MCCDQLDGOIFDGF-UHFFFAOYSA-N; [M+H]+; N,N-dimethyltetradecan-2-amine oxide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; JPNCZSADMGXVPA-UHFFFAOYSA-N; [M+H]+; 3-tridecoxypropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.993; CUFBDUDYFHCIOH-UHFFFAOYSA-N; [M+H]+; 3-(11-methyldodecoxy)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -80.252; ZUEIVCHBEQAIAL; [M+H]+; 2-(Tetradecylamino)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -91.346; JPNCZSADMGXVPA; [M+H]+; 3-Tridecoxypropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -129.395; XXELRZPDKMOXBT; [M+H]+; 3-(6-propyldecoxy)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -143.508; JCBFWZDDDTVBFC; [M+H]+; 3-(8,10-dimethylundecoxy)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.232; IDROXUWVODOXTL; [M+H]+; dodecyl-(2-hydroxyethyl)-dimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.856; CUFBDUDYFHCIOH; [M+H]+; 3-isotridecyloxy propylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.095; ONHFWHCMZAJCFB; [M+H]+; Myristamine oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.171; ZUEIVCHBEQAIAL; [M+H]+; 2-(Tetradecylamino)ethanol
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C16H36N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.429
MS$FOCUSED_ION: PRECURSOR_M/Z 258.279227
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-2090000000-bc4a3f2d7c9422f957d9
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0544703 13.5568 55.055178 0.9627 4.70 0.3662 26 f{C4H7}/4.43ppm,p-C12H29N1O1
  57.0701335 154.9741 57.070850 0.6483 15.37 0.9073 35 f{C4H9}/4.50ppm,p-C12H27N1O1
  58.0653697 26.7009 58.066090 0.8267 6.10 0.7728 35 f{C3H8N1}/4.20ppm,p-C13H28O1
  62.0602673 68.1536 62.061000 0.6929 8.51 0.8683 35 f{C2H8N1O1}/3.66ppm,p-C14H28
  71.0856568 62.0930 71.086400 0.6752 9.74 0.8683 35 f{C5H11}/1.83ppm,p-C11H25N1O1
  85.1012189 23.8182 85.101930 1.1516 4.66 0.8249 34 f{C6H13}/0.49ppm,p-C10H23N1O1
  240.2685310 46.0281 240.268890 1.3901 7.01 0.8573 31 f{C16H34N1}/-0.19ppm,p-H2O1
  256.2635498 53.0692 256.263924 1.0224 22.57 0.1207 26 f{C16H34N1O1}/0.23ppm,p-H2
  256.2997381 44.3055 256.300112 1.6348 14.61 0.2704 28 ?
  257.2664995 39.7506 257.266874 1.8075 17.26 -0.2477 25 ?
  258.2791942 999.0000 258.279570 0.3214 0.00 1.0000 35 f{C16H36N1O1}/0.21ppm,p
  259.2824633 116.8637 259.282840 0.9179 11.93 0.9417 35 ?
PK$NUM_PEAK: 12
PK$PEAK: m/z int. rel.int.
  55.054470 13.56 13
  57.070134 154.97 154
  58.065370 26.70 26
  62.060267 68.15 68
  71.085657 62.09 62
  85.101219 23.82 23
  240.268531 46.03 46
  256.263550 53.07 53
  256.299738 44.31 44
  257.266500 39.75 39
  258.279194 999.00 999
  259.282463 116.86 116
//
